United States · FDA National Drug Code directory

Hydralazine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63323-614_bf1b7c2f-535c-45bb-928a-65606d87685e
Product NDC: 63323-614
Form: INJECTION
Composition / generic term: HYDRALAZINE HYDROCHLORIDE
Labeler: Fresenius Kabi USA, LLC
Marketing category: ANDA
Marketing start / end (source format): 20010905
Source listing expiry: 20261231

Source-listed ingredients

HYDRALAZINE HYDROCHLORIDE — 20 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

25 VIAL, SINGLE-DOSE in 1 CARTON (63323-614-06) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-614-03) · 63323-614-06

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →